Kidney stones: a global picture of prevalence, incidence, and associated risk factors

Victoriano Romero, Haluk Akpinar, Dean G Assimos, Victoriano Romero, Haluk Akpinar, Dean G Assimos

Abstract

The prevalence and incidence of nephrolithiasis is reported to be increasing across the world. Herein, we review information regarding stone incidence and prevalence from a global perspective. A literature search using PubMed and Ovid was performed to identify peer-reviewed journal articles containing information on the incidence and prevalence of kidney stones. Key words used included kidney stone prevalence, incidence, and epidemiology. Data were collected from the identified literature and sorted by demographic factors and time period. A total of 75 articles were identified containing kidney stone-related incidence or prevalence data from 20 countries; 34 provided suitable information for review. Data regarding overall prevalence or incidence for more than a single time period were found for 7 countries (incidence data for 4 countries; prevalence data for 5 countries). These included 5 European countries (Italy, Germany, Scotland, Spain, and Sweden), Japan, and the United States. The body of evidence suggests that the incidence and prevalence of kidney stones is increasing globally. These increases are seen across sex, race, and age. Changes in dietary practices may be a key driving force. In addition, global warming may influence these trends.

Keywords: Epidemiology; Kidney stones; Nephrolithiasis; Stone incidence.

Figures

Figure 1
Figure 1
2005 Iran kidney stone incidence by age group. A rise-and-fall pattern is observed for reported incidence rates in Iran during 2005. Peak incidence is observed in the 40- to 49-year-old age group.
Figure 2
Figure 2
Japan kidney stone incidence by age group. Incidence data reported for Japanese men (A) and women (B) show a consistent rise-and-fall pattern in every year of reporting. Male peak incidence occurs between ages 40 and 49 years, whereas female peak incidence occurs between ages 50 and 59 years. One can also observe an increase in incidence over time in both men and women.
Figure 3
Figure 3
1986 United States kidney stone incidence by age group. A rise-and-fall pattern is observed for reported incidence rates in the United States during 1986. Peak incidence is observed between ages 45 and 49 years.
Figure 4
Figure 4
Germany kidney stone prevalence by age group. An increasing prevalence is observed for Germans as they age. This trend is observed in both 1979 and 2001.
Figure 5
Figure 5
1996 Iceland kidney stone prevalence by age group. An increasing prevalence is observed in Iceland as the population ages. This trend is observed in both men and women.
Figure 6
Figure 6
2005 Iran kidney stone prevalence by age group. Prevalence increases with increasing age among Iran’s population up until age 50 to 59 years, after which it remains stable.
Figure 7
Figure 7
1993 Italian kidney stone prevalence by age group. An increasing prevalence with increasing age is observed in Italy for both men and women.
Figure 8
Figure 8
2006 Thebes, Greece, kidney stone prevalence by age group. An increasing prevalence is observed with increasing age among those living in Thebes for both men and women.
Figure 9
Figure 9
1989 Turkey kidney stone prevalence by age group. An increasing prevalence of kidney stones is observed as the population ages.
Figure 10
Figure 10
US kidney stone prevalence by age group. In 1978, prevalence in US men and women demonstrates a rise-and-fall pattern as the population ages, with peak prevalence occurring between age 60 and 69 years in men, and between age 50 and 59 in women. In 1991, prevalence continues increasing with advancing age in men, although remaining stable in women age > 59 years.
Figure 11
Figure 11
Milan, Italy, kidney stone prevalence by age group. An increasing prevalence is observed with increasing age among those living in Milan, but a prevalence decrease occurs after age > 60 years.
Figure 12
Figure 12
1998 Korea kidney stone prevalence by age group. Korean men demonstrated a decrease in stone prevalence with increasing age. Korean women demonstrated a rise-and-fall pattern, with peak incidence occurring between age 60 and 69 years.
Figure 13
Figure 13
US kidney stone prevalence rates by race. Data for kidney stone prevalence rates show rates being lowest in Asian women (A) and highest in white men (B). CPS, Cancer Prevention Study; NHANES, National Health and Nutrition Examination Survey.
Figure 14
Figure 14
US kidney stone prevalence by race and age group. An increasing prevalence with increasing age is observed in US white and black men for both reporting periods. Prevalence has nearly doubled for black men in the 60- to 74-year-old age group between the 2 time periods.

References

    1. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982;115:255–265.
    1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–1823.
    1. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–899.
    1. Sánchez-Martín FM, Millán Rodríguez F, Esquena Fernández S, et al. Incidence and prevalence of published studies about urolithiasis in Spain: a review [article in Spanish] Actas Urol Esp. 2007;31:511–520.
    1. Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int. 2004;72(suppl 1):1–5.
    1. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999;81(suppl l):26–30.
    1. Hesse A, Brändle E, Wilbert D, et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44:709–713.
    1. Trinchieri A, Coppi F, Montanari E, et al. Increase in the prevalence of symptomatic urinary tract stones during the last ten years. Eur Urol. 2000;37:23–25.
    1. Scott R, Freeland R, Mowat W, et al. The prevalence of calcified upper urinary tract stone disease in a random population-Cumbernauld Health Survey. Br J Urol. 1977;49:589–595.
    1. Scott R. Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. Br J Urol. 1987;59:111–117.
    1. Akinci M, Esen T, Tellaloğlu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol. 1991;20:200–203.
    1. Indridson OS, Birgisson SJ, Edvardsson VO, et al. Epidemiology of kidney stones in Iceland: a population-based study. Scand J Urol Nephrol. 2006;40:215–220.
    1. Pinduli I, Spivacow R, del Valle E, et al. Prevalence of urolithiasis in the autonomous city of Buenos Aires, Argentina. Urol Res. 2006;34:8–11.
    1. Stamatiou KN, Karanasiou VI, Lacroix RE, et al. Prevalence of urolithiasis in rural Thebes, Greece. Rural Remote Health. 2006;6:610.
    1. Yanagawa M, Kawamura J, Onishi T, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997;4:537–540.
    1. Kim H, Jo MK, Kwak CK, et al. Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology. 2002;594:517–521.
    1. Grases F, Conte A, March JG, et al. Epidemiology of urinary stone disease in the Balearic Islands Community. Int Urol Nephrol. 1994;26:145–150.
    1. Lee YH, Huang WC, Tsai JY, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int. 2002;68:172–177.
    1. Thun MJ, Schober S. Urolithiasis in Tennessee: an occupational window into a regional problem. Am J Public Health. 1991;81:587–591.
    1. Sierakowski R, Finlayson B, Landes RR, et al. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol. 1978;15:438–441.
    1. Saigal CS, Joyce G, Timilsina AR. Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808–1814.
    1. Johnson CM, Wilson DM, O’Fallon WM, et al. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–631.
    1. Lieske JC, Peña de la Vega JS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760–764.
    1. Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71:209–213.
    1. Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int. 1999;56:1899–1904.
    1. Iguchi M, Umekawa T, Katoh Y, et al. Prevalence of urolithiasis in Kaizuka City, Japan-an epidemiologic study of urinary stones. Int J Urol. 1996;3:175–179.
    1. Safarinejad MR. Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res. 2007;35:73–82.
    1. Fujita K. Epidemiology of urinary stone colic. Eur Urol. 1979;5:26–28.
    1. Buchholz N, Abbas F, Afzal M, et al. The prevalence of silent kidney stones—an ultrasonographic screening study. J Pak Med Assoc. 2003;53:24–25.
    1. Emamian SA, Nielsen MB, Pedersen JF, Ytte L. Sonographic evaluation of renal appearance in 665 adult volunteers. Correlation with age and obesity. Acta Radiol. 1993;34:482–485.
    1. Oshibuchi M, Nishi F, Sato M, et al. Frequency of abnormalities detected by abdominal ultrasound among Japanese adults. J Gastroenterol Hepatol. 1991;6:165–168.
    1. López M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25:49–59.
    1. Cohen MN. Health and Rise of Civilization. New Haven, CT: Yale University Press; 1991.
    1. Taylor EN, Stampfer M, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–462.
    1. National Center for Health Statistics. Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics; 2010. p. 27.
    1. Adair LS, Popkin BM. Are child eating patterns being transformed globally? Obes Res. 2005;13:1281–1299.
    1. Zhai F, Wang H, Du S, et al. Lifespan nutrition and changing socio-economic conditions in China. Asia Pac J Clin Nutr. 2007;16(suppl l):374–382.
    1. Shetty PS. Nutrition transition in India. Public Health Nutr. 2002;5(1A):175–182.
    1. Galal OM. The nutrition transition in Egypt: obesity, undernutrition and the food consumption context. Public Health Nutr. 2002;5(1A):141–148.
    1. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int. 2008;73:207–212.
    1. Borghi L, Ferretti PP, Elia GF, et al. Epidemiological study of urinary tract stones in a northern Italian city. Br J Urol. 1990;65:231–235.
    1. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128:534–540.
    1. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–1573.
    1. Hirvonen T, Pietinen P, Virtanen M, et al. Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am J Epidemiol. 1999;150:187–194.
    1. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402–2410.
    1. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198–2204.
    1. Engstrom A, Tobelmann RC, Albertson AM. Sodium intake trends and food choices. Am J Clin Nutr. 1997;65(suppl):704S–707S.
    1. Contribution of Working Groups I, II and III to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change [Core Writing Team, Pachauri RK, Reisinger A, eds.] Geneva, Switzerland: IPCC; 1977. Intergovernmental Panel on Climate Change. Climate Change 2007: Synthesis Report.
    1. Brikowski TH, Lotan Y, Pearle MS. Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA. 2008;105:9841–9846.
    1. Evans K, Costabile RA. Time to development of symptomatic urinary calculi in a high risk environment. J Urol. 2005;173:858–861.
    1. Doumerc N, Game X, Mouzin M, et al. Suggestion of a two-month delay between extreme temperatures and renal colic. J Urol. 2008;179(suppl):481.
    1. Curhan GC, Rimm EB, Willett WC, Stampfer MJ. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol. 1994;151:838–841.
    1. Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171:1920–1924.
    1. Rule AD, Bergstralh EJ, Melton LJ, 3rd, et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804–811.
    1. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–1235.
    1. Hamano S, Nakatsu H, Suzuki N, et al. Kidney stone disease and risk factors for coronary heart disease. Int J Urol. 2005;12:859–863.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit